Gabapentinoids: a therapeutic review
Akshay Athavale, Bridin Murnion · 2023
Read Gabapentinoids: a therapeutic review by Akshay Athavale, Bridin Murnion (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10751078.txt.
Description
Akshay Athavale and Bridin Murnion review a drug family used for seizures and nerve pain. The drugs are gabapentinoids, sold for a short list of cleared uses. In Australia they are cleared for stubborn focal epilepsy and nerve pain. Use for vague back or leg pain is common, yet proof for it is thin.
The drugs can cause a mild high, sleepiness, and loose control, which invites misuse. Harm from misuse, both by chance and on purpose, has climbed. Long use can breed dependence, and a sudden stop can bring withdrawal. If the reason for use is murky, the authors urge a slow taper off. Kidney trouble raises the risk of harm. Each new script, they say, needs a clear weighing of help against harm.
Catalog record
| CREATOR | Akshay Athavale, Bridin Murnion |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |